These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10884457)

  • 1. Acute ischemic stroke : polymorphonuclear leukocyte membrane fluidity and cytosolic Ca(2+) concentration at baseline and after chemotactic activation.
    Caimi G; Ferrara F; Montana M; Meli F; Canino B; Carollo C; Presti RL
    Stroke; 2000 Jul; 31(7):1578-82. PubMed ID: 10884457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte rheology before and after chemotactic activation in some venous diseases.
    Caimi G; Canino B; Ferrara F; Montana M; Raimondi F; LoPresti R
    Eur J Vasc Endovasc Surg; 1999 Nov; 18(5):411-6. PubMed ID: 10610829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential hypertension: leukocyte rheology and polymorphonuclear cytosolic Ca2+ content at baseline and after activation.
    Caimi G; Lo Presti R; Canino B; Montana M; Ferrara L; Oddo G; Ventimiglia G; Cerasola G
    Clin Hemorheol Microcirc; 1998 Dec; 19(4):281-9. PubMed ID: 9972665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca(2+) content in young adults with acute myocardial infarction. Evaluation at the initial stage and after 12 months.
    Caimi G; Hoffmann E; Canino B; Montana M; Dispensa F; Incalcaterra E; Casciolo MF; Catania A; Lo Presti R
    Clin Hemorheol Microcirc; 2004; 31(1):41-7. PubMed ID: 15272152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus: polymorphonuclear leukocyte (PMN) filtration parameters and PMN membrane fluidity after chemotactic activation.
    LoPresti R; Montana M; Canino B; Ventimiglia G; Catania A; Caimi G
    Metabolism; 1999 Jan; 48(1):30-3. PubMed ID: 9920141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type II diabetics with macrovascular complications: polymorphonuclear leukocyte (PMN) filtration, PMN membrane fluidity and cytosolic Ca2+ content after activation.
    Caimi G; Lo Presti R; Montana M; Ferrara F; Ventimiglia G; Meli F; Catania A; Canino B
    Horm Metab Res; 1998 Feb; 30(2):72-6. PubMed ID: 9543687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep venous thrombosis: leukocyte rheology at baseline and after in vitro activation.
    LoPresti R; Ferrara F; Canino B; Montana M; Caimi G
    Haemostasis; 2000; 30(4):168-73. PubMed ID: 11155035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphonuclear leukocyte membrane fluidity before and after activation in subjects with insulin resistance.
    Caimi G; Sinagra D; Canino B; Scarpitta AM; Montana M; Bonaventura V; Lo Presti R
    Acta Diabetol; 2000 Mar; 37(1):9-12. PubMed ID: 10928230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of the altered polymorphonuclear leukocyte rheological and metabolic variables after 12 months in juvenile myocardial infarction.
    Lo Presti R; Tozzi Ciancarelli MG; Hoffmann E; Incalcaterra E; Canino B; Montana M; D'Amico T; Catania A; Caimi G
    Clin Hemorheol Microcirc; 2006; 35(1-2):227-30. PubMed ID: 16899933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphonuclear leukocyte membrane fluidity, at baseline and after in vitro activation, in obesity with or without diabetes mellitus.
    Lo Presti R; Sinagra D; Montana M; Scarpitta AM; Catania A; Caimi G
    Acta Diabetol; 2002 Apr; 39(1):29-33. PubMed ID: 12043936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ concentration in subjects with vascular atherosclerotic disease subdivided according to its extent.
    Lo Presti R; Tozzi Ciancarelli MG; Canino B; Carollo C; Lucido D; Amodeo G; Romano A; Caimi G
    Clin Hemorheol Microcirc; 2006; 35(1-2):199-201. PubMed ID: 16899927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise test: trend of the leukocyte flow properties, polymorphonuclear membrane fluidity and cytosolic Ca2+ content in normals, in subjects with previous acute myocardial infarction and in subjects with aortocoronary by-pass.
    Caimi G; Assennato P; Canino B; Montana M; Ventimiglia G; Lo Presti R
    Clin Hemorheol Microcirc; 1997; 17(2):127-35. PubMed ID: 9255436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphonuclear integrins, membrane fluidity, and cytosolic Ca(2+) content after activation in essential hypertension.
    Caimi G; Presti RL; Carollo C; Musso M; Porretto F; Canino B; Catania A; Cerasola G
    Hypertension; 2000 Nov; 36(5):813-7. PubMed ID: 11082148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference in changes of membrane fluidity of polymorphonuclear leukocytes stimulated with phorbol myristate acetate and formyl-methionyl-leucyl-phenylalanine: role of excited oxygen species.
    Masuda M; Komiyama Y; Murakami T; Murata K; Hasui M; Hirabayashi Y; Kobayashi Y
    J Leukoc Biol; 1990 Feb; 47(2):105-10. PubMed ID: 2303745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic renal failure: leukocyte rheology and polymorphonuclear cytosolic Ca2+ concentration.
    Lo Presti R; Canino B; Vaccaro F; Montana M; Ventimiglia G; Grifò G; Caimi G
    Curr Med Res Opin; 1999; 15(3):202-7. PubMed ID: 10621927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphonuclear leukocyte: rheology, metabolism and integrin pattern in vascular atherosclerotic disease and in type 2 diabetes mellitus.
    Caimi G; Lo Presti R; Montana M; Carollo C; Amodeo G; Romano A; Canino B
    Clin Hemorheol Microcirc; 2004; 30(3-4):229-35. PubMed ID: 15258348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ content in different clinical conditions.
    Caimi G; Canino B; Montana M; Ventimiglia G; Catania A; Lo Presti R
    Clin Hemorheol Microcirc; 1997; 17(3):217-23. PubMed ID: 9356786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavior of the polymorphonuclear leukocyte membrane fluidity and cystolic Ca2+ content in vascular atherosclerotic disease with and without non-insulin-dependent diabetes mellitus.
    Caimi G; Canino B; Montana M; Ferrara F; Ventimiglia G; Meli F; Romano A; Catania A; Lo Presti R
    Clin Hemorheol Microcirc; 1997; 17(6):429-36. PubMed ID: 9502527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte flow properties, polymorphonuclear membrane fluidity, and cytosolic Ca2+ content in subjects with vascular atherosclerotic disease with and without noninsulin-dependent diabetes mellitus.
    Caimi G; Canino B; Ferrara F; Montana M; Meli F; Catania A; Lo presti R
    Angiology; 1996 Aug; 47(8):757-63. PubMed ID: 8712478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte integrins before and after activation in acute ischaemic stroke.
    Caimi G; Canino B; Ferrara F; Montana M; Musso M; Porretto F; Carollo C; Catania A; Lo Presti R
    J Neurol Sci; 2001 May; 186(1-2):23-6. PubMed ID: 11412867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.